Annual Drug Patent Expirations for ALIMTA
Alimta is a drug marketed by Lilly and is included in one NDA. It is available from one supplier. There is one patent protecting this drug and four Paragraph IV challenges.
Drug patent litigation for ALIMTA.
The generic ingredient in ALIMTA is pemetrexed disodium. One supplier is listed for this compound. Additional details are available on the pemetrexed disodium profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com